Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Roopa Industries's long-term debt to total assests ratio for the quarter that ended in Jun. 2026 was 0.00.
Roopa Industries's long-term debt to total assets ratio
stayed the same
from Jun. 2025 (0.00) to Jun. 2026 (0.00).
LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.
Roopa Industries LT-Debt-to-Total-Asset Related Terms
Roopa Industries LT-Debt-to-Total-Asset Historical Data
* Premium members only.
The historical data trend for Roopa Industries's LT-Debt-to-Total-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Roopa Industries (BOM:530991) has a LT-Debt-to-Total-Asset of 0.00 as of Jun. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Roopa Industries and its competitors.
Is Roopa Industries' LT-Debt-to-Total-Asset too high?
Roopa Industries' current LT-Debt-to-Total-Asset is 0.00. Overall, Roopa Industries has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Roopa Industries' LT-Debt-to-Total-Asset compare to DOW?
Roopa Industries' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Chemicals company?
A good LT-Debt-to-Total-Asset depends on the Chemicals industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Roopa Industries and its competitors. Roopa Industries's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roopa Industries stock overvalued right now?
Based on GuruFocus' analysis, Roopa Industries (BOM:530991) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹101.77, compared to a current price of ₹52.40 — trading 48.5% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Roopa Industries' overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Roopa Industries (BOM:530991), the current LT-Debt-to-Total-Asset is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Roopa Industries (BOM:530991) Overvalued in 2026?
Based on GuruFocus' analysis, Roopa Industries stock appears to be undervalued.
The current stock price of ₹52.40 is trading 48.5% below its estimated GF Value™ of ₹101.77.
GuruFocus considers Roopa Industries to be Significantly Undervalued.
Key valuation signals for BOM:530991:
LT-Debt-to-Total-Asset: 0.00
GF Value™: ₹101.77 vs. price of ₹52.40 (48.5% below fair value)
No single metric tells the full story. See the BOM:530991 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Roopa Industries Ltd is an Indian Active Pharma Ingredient(API) and Pharmaceutical Intermediates company engaged in manufacturing, selling and exporting nutraceuticals, bulk drugs, and fine chemicals. It offers glucosamine, a nutraceutical/nutritional supplement used for arthritis treatment; and triphenylphosphine, which have applications in antibiotics, statins, specialty resins/paints, fire retardants, phosphonium salts, phase transfer catalysts, agriculture-related products as well as in organic synthesis. The other products offered by the company include Bromine and its derivatives, Esomeprazole Magnesium Trihydrate, and Tamsulosin. The company generates all of its revenue from the sale of its products.
75GF Score
Get the complete analysis for BOM:530991
LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530991 has been successfully added to your 
